Business law

(HRC): Johnson Fistel Investigates Proposed Sale of Hill-Rom; Are Shareholders Getting a Fair Deal?

Retrieved on: 
Saturday, September 4, 2021
Financial markets, Stock market, Equity securities, Finance, Financial economics, Corporate finance, Corporate law, Board of directors, Business law, Stock, New York Stock Exchange, Shareholder

The investigation concerns whether the Hill-Rom board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Hill-Rom shares of common stock.

Key Points: 
  • The investigation concerns whether the Hill-Rom board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Hill-Rom shares of common stock.
  • Nationally recognized, Johnson Fistel is investigating whether the proposed deal represents adequate consideration.
  • Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia.
  • The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits.

Form 8.3 - The Vanguard Group, Inc.: UDG Healthcare plc

Retrieved on: 
Wednesday, August 4, 2021
Stock market, Financial law, Security, Derivative, Electronic voting, Finance, Articles, Business law, Regulation S-K

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 27 March 2021 and Notice of Annual General Meeting 2021

Retrieved on: 
Wednesday, August 4, 2021
Articles, Corporate law, Committees, Financial statements, Board of directors, Business law, Business, Pension

Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Key Points: 
  • Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
  • The Directors who were members of the Board at the time of approving the Directors' Report are listed on pages 40 and 41.
  • This analysis is not intended to be a comprehensive list of all risks actively managed by the business.
  • During the current and prior years the Company provided various administrative services to the Fuller, Smith & Turner Pension Plan free of charge.

IntelGenx Strengthens Board with the Appointments of Dr. Srinivas G. Rao and Frank Stegert

Retrieved on: 
Wednesday, August 4, 2021
Articles, Board of directors, Business law, Committees, Corporate law

SAINT LAURENT, Quebec, Aug. 04, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp.(TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced the appointments of Srinivas (Srini) G. Rao, M.D., Ph.D. and Frank Stegert to its Board of Directors.

Key Points: 
  • SAINT LAURENT, Quebec, Aug. 04, 2021 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp.(TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced the appointments of Srinivas (Srini) G. Rao, M.D., Ph.D. and Frank Stegert to its Board of Directors.
  • With the appointments, the size of the Companys Board of Directors increased from six to eight.
  • Dr. Rao has been assigned to the Compensation Committee of the Board and Mr. Stegert has been assigned to the Corporate Governance and Nominations Committee of the Board.
  • IntelGenx is a leading drug delivery company focused on the development and manufacturing of pharmaceutical films.

Decisions Taken by Citycon Oyj's Board of Directors' Organising Meeting

Retrieved on: 
Wednesday, August 4, 2021
Articles, Parliamentary procedure, Corporate law, Committees, Board of directors, Business law, Committee, Chairperson

https://news.cision.com/citycon-oyj/r/decisions-taken-by-citycon-oyj-s-b...

Key Points: 
  • HELSINKI, Aug. 4, 2021 /PRNewswire/ -- At its organising meeting held after the Extraordinary General Meeting held on 2 August 2021 Citycon Oyj's Board of Directors decided to elect Mr Alexandre (Sandy) Koifman as a deputy chairman of the Board of Directors and as a chairman of the Board of Directors' Audit and Governance Committee.
  • Furthermore, the Board of Directors decided to elect Ms Ljudmila Popova as a member of the Board of Directors' Audit and Governance Committeeand Mr Per-Anders Ovin as a member of the Board of Directors' Nomination and Remuneration Committee.
  • After the Committee membership elections the compositions of Board of Directors' Committees are as follows:

EBA consults on new Guidelines on the role of AML/CFT compliance officers

Retrieved on: 
Wednesday, August 4, 2021
Crime, Financial regulation, Money laundering, Tax evasion, Terrorism, Terrorism financing, European Banking Authority, Business law, Articles, Asia/Pacific Group on Money Laundering

02 August 2021

Key Points: 
  • 02 August 2021

    The European Banking Authority (EBA) launched today a public consultation on new Guidelines on the role, tasks and responsibilities of anti-money laundering and countering the financing of terrorism (AML/CFT) compliance officers.

  • Once adopted, these Guidelines will apply to all financial sector operators that are within the scope of the AML Directive.
  • The draft Guidelines comprehensively address, for the first time at the level of the EU, the whole AML/CFT governance set-up.
  • In drafting these guidelines, the EBA fulfills a request by the Commissions request in its Supra-National Risk Assessment (SNRA) of 2019 to develop guidance that clarifies the role of AML/CFT compliance officers in credit and financial institutions.

Canton & Company Executives Named to Board of Directors for Monarch Health Solutions

Retrieved on: 
Wednesday, August 4, 2021
Articles, Business, Board of directors, Business law, Committees, Corporate law, Chairperson

BALTIMORE, Aug. 4, 2021 /PRNewswire/ -- Canton & Company (Canton), a leading healthcare growth and innovation firm, today announced that three of its executives have been tapped to serve as members of the Board of Directors for Monarch Health Solutions (Monarch).

Key Points: 
  • BALTIMORE, Aug. 4, 2021 /PRNewswire/ -- Canton & Company (Canton), a leading healthcare growth and innovation firm, today announced that three of its executives have been tapped to serve as members of the Board of Directors for Monarch Health Solutions (Monarch).
  • The executives appointed to the Monarch Board of Directors include:
    Don McDaniel, Canton & Company, CEO , a longtime industry thought leader with deep experience in the health center space will serve as the Board's Vice Chairperson.
  • "It's an honor to serve on this organization's Board of Directors," said McDaniel.
  • "I am thrilled to be part of the Monarch Health Solutions Board which has an incredibly important mission," said Hertzog.

Form 8.3 - The Vanguard Group, Inc.: UDG Healthcare plc

Retrieved on: 
Wednesday, August 4, 2021
Stock market, Financial law, Security, Derivative, Electronic voting, Finance, Articles, Business law, Regulation S-K

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

ScottsMiracle-Gro Announces the Appointment of Former TopBuild Corp CEO Gerald Volas to its Board of Directors

Retrieved on: 
Tuesday, August 3, 2021
Articles, Corporate law, Committees, Board of directors, Business law, Audit committee, Committee

Mr. Volas served as Chief Executive Officer and a director of TopBuild Corp., a leading installer and distributor of insulation products, between June 2015 and December 2020.

Key Points: 
  • Mr. Volas served as Chief Executive Officer and a director of TopBuild Corp., a leading installer and distributor of insulation products, between June 2015 and December 2020.
  • He is a seasoned professional and I am confident that his voice on the Board will help bring continued value for our shareholders.
  • On behalf of all the directors, I welcome him to the Board.
  • Mr. Volas will serve on the Companys Audit Committee and Finance Committee with a term that expires in 2023.

Scott+Scott Attorneys at Law LLP Investigates Social Capital Hedosophia Holding Corp. III’s Directors and Officers for Breach of Fiduciary Duties – IPOC, CLOV

Retrieved on: 
Tuesday, August 3, 2021
Legal, Professional services, Articles, Corporate law, Board of directors, Business law, Committees, Fiduciary

Scott+Scott Attorneys at Law LLP (Scott+Scott), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of Social Capital Hedosophia Holdings Corp. III (SCH III) (NYSE: IPOC), now known as Clover Health Investments, Corp. (Clover Health) (NASDAQ: CLOV) breached their fiduciary duties to SCH III and its shareholders.

Key Points: 
  • Scott+Scott Attorneys at Law LLP (Scott+Scott), an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of Social Capital Hedosophia Holdings Corp. III (SCH III) (NYSE: IPOC), now known as Clover Health Investments, Corp. (Clover Health) (NASDAQ: CLOV) breached their fiduciary duties to SCH III and its shareholders.
  • If you were an SCH III shareholder, you may contact attorney Joe Pettigrew for additional information toll-free at 844-818-6982 or [email protected] .
  • Scott+Scott is investigating whether SCH IIIs board of directors or senior management failed to manage SCH III in an acceptable manner, in breach of their fiduciary duties to SCH III shareholders, and whether SCH IIIs shareholders suffered damages as a result.
  • If you were an SCH III shareholder, you may have legal claims against SCH IIIs directors and officers.